BCL2 and neoplasm: Pharmaco-logically, Gentiana extracts target NF-κB and MAPK pathways to suppress in-flammation and oxidative liver injury via Nrf2 activation, while inducing tumor cell apoptosis (Bax/Bcl-2) and S/G2-M phase arrest to inhibit lung/liver cancer proliferation.